Active, Not Recruiting
Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer
NCT06027268
- Conditions
- Breast Diseases, Breast Neoplasms, Metastatic Triple-negative Breast Cancer, +9 more
- Locations
-
- Levine Cancer Institute Charlotte, North Carolina, United States